Trial record 1 of 1 for:    NCT01250470
Previous Study | Return to List | Next Study

Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01250470
First received: November 24, 2010
Last updated: July 25, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)